Antiviral nasal and sinus decongestant spray device for treating colds

Abstract

The invention discloses an antiviral nasal cavity and sinus anticongestant spray device for treating colds, which includes a bottom plate and a liquid medicine storage bottle, inserts two symmetrically arranged silicone nozzles into the patient's nasal cavity, turns on the electronic atomizer, and goes back and forth. Press the three-way connection tube to squeeze the air through the extrusion block, compress the return spring, and compress the liquid to flow out of the catheter tube, atomize and spray it through the electronic nebulizer, and reach the nasal cavity of the patient. The electronically atomized drug is sprayed out by the nozzle and then inhaled by the common cold patient. The drug can reach the entire nasal cavity and sinus infected mucosa and achieve a good therapeutic effect. It can reach the sinus cavity and Eustachian tube that are difficult to reach with ordinary spray. And the upper respiratory tract, avoiding various adverse reactions of systemic medication, increasing local drug concentration, clinical trials have found that it can greatly shorten the course of colds, and the silicone nozzle avoids nasal mucosa damage that may be caused by excellent plastic nozzles, especially suitable for people who are prone to common colds Children have great clinical application prospects.

Description

technical field [0001] The invention relates to a spray device, in particular to a spray device for an antiviral nasal cavity and sinus anticongestant agent for treating colds. Background technique [0002] The common cold is a disease with the highest incidence rate in humans. Adults have 2-3 colds per year on average, and children have 6-8 colds. At present, there is no western medicine, traditional Chinese medicine or Chinese patent medicine that has been proven to shorten the natural course of the common cold. Treatment is limited to relieving symptoms, and although most patients claim to benefit from treatment, it is mostly a placebo effect. At present, the main components of the treatment of the common cold are analgesics and antipyretics. Studies have shown that these drugs may cause potential harm to children. For example, Canada has restricted children aged 6 and under from taking these drugs. For symptoms of runny nose, antihistamines can be taken to relieve the...

AI Technical Summary

Problems solved by technology

Studies have shown that these drugs may cause potential harm to children. For example, Canada has restricted children aged 6 and under from taking these drugs

For symptoms of runny nose, antihistamines can be taken to relieve the symptoms, but they may cause adverse reactions of drowsiness, and have limited effect on relieving nasal congestion symptoms

[0003] At present, cold medicine is basically used for the whole body, but after the first-pass elimination of the blood circulation liver and redistribution throughout the body, it can really reach the localized disease. The amount of medicine for the congested nasal cavity and sinus mucosa is very limited, and it is difficult to achieve therapeutic effect. The important reason why the medicine cannot shorten the course of the cold, for this reason, it has to suffer from the adverse reactions and side effects of the systemic medicine

Images